logo

Miragen Therapeutics, Inc. (MGEN)



Trade MGEN now with
  Date
  Headline
3/18/2019 6:37:26 AM Wedbush Is Cutting MIRAGEN THERAPEUTICS, INC. (MGEN) FY20 Estimate To -1.83 From -1.59
3/18/2019 6:35:45 AM Wedbush Is Lowering MIRAGEN THERAPEUTICS, INC. (MGEN) Q4 20 Estimate To -0.47 From -0.40
3/18/2019 6:35:32 AM Wedbush Is Cutting MIRAGEN THERAPEUTICS, INC. (MGEN) Q3 20 Estimate To -0.46 From -0.40
3/18/2019 6:35:18 AM Wedbush Is Cutting MIRAGEN THERAPEUTICS, INC. (MGEN) Q2 20 Estimate To -0.45 From -0.39
3/18/2019 6:35:08 AM Wedbush Is Lowering MIRAGEN THERAPEUTICS, INC. (MGEN) Q1 20 Estimate To -0.45 From -0.39
3/18/2019 6:34:50 AM Wedbush Is Lowering MIRAGEN THERAPEUTICS, INC. (MGEN) FY19 Estimate To -1.54 From -1.30
3/18/2019 6:34:28 AM Wedbush Is Lowering MIRAGEN THERAPEUTICS, INC. (MGEN) Q4 19 Estimate To -0.39 From -0.33
3/18/2019 6:34:14 AM Wedbush Is Cutting MIRAGEN THERAPEUTICS, INC. (MGEN) Q3 19 Estimate To -0.39 From -0.33
3/18/2019 6:33:50 AM Wedbush Is Cutting MIRAGEN THERAPEUTICS, INC. (MGEN) Q2 19 Estimate To -0.38 From -0.32
3/18/2019 6:33:37 AM Wedbush Is Cutting MIRAGEN THERAPEUTICS, INC. (MGEN) Q1 19 Estimate To -0.38 From -0.32
3/18/2019 6:32:50 AM Wedbush Reiterates MIRAGEN THERAPEUTICS, INC. (MGEN) At Outperform With $24 Up From $22 Price Target
12/20/2018 7:12:01 AM MiRagen Therapeutics To Present New Cobomarsen Clinical Trial Data For ATLL And CTCL At Annual T-Cell Lymphoma Forum
12/2/2018 5:45:21 PM Seattle Highlights Addl Analyses From ECHELON-1 Phase 3 Trial Of ADCETRIS In Newly Diagnosed Advanced Hodgkin Lymphoma
12/2/2018 5:42:03 PM MiRagen Announces Data From Phase 1 Cobomarsen Clinical Trial In Patients With Mycosis Fungoides
10/8/2018 3:35:56 PM Wedbush Reiterates MIRAGEN THERAPEUTICS, INC. (MGEN) At Outperform With $19 Price Target
8/8/2018 9:46:01 AM Wedbush Is Raising MIRAGEN THERAPEUTICS, INC. (MGEN) FY19 Rev. Estimate To 10728 M From 3209 M
8/8/2018 9:45:51 AM Wedbush Is Raising MIRAGEN THERAPEUTICS, INC. (MGEN) FY18 Rev. Estimate To 10728 M From 7190 M
8/8/2018 9:45:21 AM Wedbush Is Raising MIRAGEN THERAPEUTICS, INC. (MGEN) Q3 18 Rev. Estimate To 2682.0 M From 802.3 M